文献速递糖尿病

HLA-DQ异二聚体-18β和β57残基与1型糖尿病预防试验中胰岛自身免疫向糖尿病进展的关联

Association of HLA-DQ Heterodimer Residues -18β and β57 With Progression From Islet Autoimmunity to Diabetes in the Diabetes Prevention Trial-Type 1.
PubMed 文献 · Diabetes Care · 2022-01-01

研究对1型糖尿病预防试验(DPT-1)中670名受试者进行HLA-DQA1-B1二代靶向测序,采用分层单倍型关联分析识别与糖尿病发病相关的基序。结果确认DQA1*03:01-B1*03:02与DQA1*03:03-B1*03:01风险相反,并发现信号肽-18β和β链β57残基构成的基序与进展速度相关。结论提示HLA-DQ结构基序可能调节高危亲属从胰岛自身免疫向糖尿病的进展。

要点

  • DQA1*03:01-B1*03:02风险比HR 1.36,DQA1*03:03-B1*03:01风险比HR 0.62。
  • DQ*VA基序与更快进展相关(HR 1.49),DQ*AD与更慢进展相关(HR 0.64)。
  • VA/VA(DQ8/8)风险比HR 1.98,且DQ*VA与胰岛细胞抗体和胰岛素自身抗体相关。

核心结论

  • HLA-DQ结构基序可能调节具有胰岛自身抗体的高危亲属从胰岛自身免疫向糖尿病的进展。
  • 信号肽内-18β残基可能与蛋白质合成水平相关,β57可能与肽-DQαβ三分子复合物稳定性相关。

研究设计与样本

  • 研究为在1型糖尿病预防试验(DPT-1)中对670名受试者进行的HLA-DQA1-B1 II类基因二代靶向测序基因分型。
  • 编码序列翻译为DQ α链和β链氨基酸残基,用于分层单倍型(HOH)关联分析以识别与糖尿病发病相关的基序。

主要发现

  • 确认HLA DQA1*03:01-B1*03:02与糖尿病风险升高相关(HR 1.36;P=2.01×10^-3),DQA1*03:03-B1*03:01与风险降低相关(HR 0.62;P=0.037)。
  • HOH分析发现信号肽-18β和β链β57形成六个基序,DQ*VA与更快进展至糖尿病发病相关(HR 1.49;P=6.36×10^-4),DQ*AD与更慢进展相关(HR 0.64;P=0.020)。
  • VA/VA代表DQA1*03:01-B1*03:02(DQ8/8),其风险比更高为1.98(P=2.80×10^-3)。
  • DQ*VA基序与胰岛细胞抗体(P=0.023)和胰岛素自身抗体(IAA)(P=3.34×10^-3)相关,DQ*AD基序与IAA频率降低相关(P=0.015)。
  • 具有DQ*VA和DQ*AD的受试者在整个随访期间分别出现HbA1c水平升高和降低的趋势。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The purpose was to test the hypothesis that the HLA-DQαβ heterodimer structure is related to the progression of islet autoimmunity from asymptomatic to symptomatic type 1 diabetes (T1D). RESEARCH DESIGN AND METHODS: Next-generation targeted sequencing was used to genotype HLA-DQA1-B1 class II genes in 670 subjects in the Diabetes Prevention Trial-Type 1 (DPT-1). Coding sequences were translated into DQ α- and β-chain amino acid residues and used in hierarchically organized haplotype (HOH) association analysis to identify motifs associated with diabetes onset. RESULTS: The opposite diabetes risks were confirmed for HLA DQA1*03:01-B1*03:02 (hazard ratio [HR] 1.36; P = 2.01 ∗ 10-3) and DQA1*03:03-B1*03:01 (HR 0.62; P = 0.037). The HOH analysis uncovered residue -18β in the signal peptide and β57 in the β-chain to form six motifs. DQ*VA was associated with faster (HR 1.49; P = 6.36 ∗ 10-4) and DQ*AD with slower (HR 0.64; P = 0.020) progression to diabetes onset. VA/VA, representing DQA1*03:01-B1*03:02 (DQ8/8), had a greater HR of 1.98 (P = 2.80 ∗ 10-3). The DQ*VA motif was associated with both islet cell antibodies (P = 0.023) and insulin autoantibodies (IAAs) (P = 3.34 ∗ 10-3), while the DQ*AD motif was associated with a decreased IAA frequency (P = 0.015). Subjects with DQ*VA and DQ*AD experienced, respectively, increasing and decreasing trends of HbA1c levels throughout the follow-up. CONCLUSIONS: HLA-DQ structural motifs appear to modulate progression from islet autoimmunity to diabetes among at-risk relatives with islet autoantibodies. Residue -18β within the signal peptide may be related to levels of protein synthesis and β57 to stability of the peptide-DQab trimolecular complex.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Zhao LP, Skyler J, Papadopoulos GK, et al. Association of HLA-DQ Heterodimer Residues -18β and β57 With Progression From Islet Autoimmunity to Diabetes in the Diabetes Prevention Trial-Type 1. Diabetes Care. 2022. PMID: 35621697. doi:10.2337/dc21-1628

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。